Boston Trust Walden’s Hanover Insurance THG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.6M Sell
138,180
-2,758
-2% -$522K 0.23% 152
2026
Q1
$24.4M Sell
140,938
-29,409
-17% -$5.11M 0.2% 162
2025
Q4
$31.1M Sell
170,347
-1,596
-0.9% -$287K 0.24% 151
2025
Q3
$31.2M Sell
171,943
-826
-0.5% -$142K 0.23% 153
2025
Q2
$29.3M Sell
172,769
-172,605
-50% -$28.8M 0.21% 160
2025
Q1
$60.1M Sell
345,374
-6,223
-2% -$1.01M 0.44% 80
2024
Q4
$54.4M Sell
351,597
-5,096
-1% -$790K 0.38% 96
2024
Q3
$52.8M Sell
356,693
-9,073
-2% -$1.25M 0.37% 110
2024
Q2
$45.9M Sell
365,766
-368
-0.1% -$47.9K 0.34% 121
2024
Q1
$49.9M Buy
366,134
+3,395
+0.9% +$441K 0.36% 115
2023
Q4
$44M Sell
362,739
-937
-0.3% -$111K 0.33% 117
2023
Q3
$40.4M Buy
363,676
+22,583
+7% +$2.49M 0.34% 107
2023
Q2
$38.6M Buy
341,093
+120,400
+55% +$14.3M 0.32% 117
2023
Q1
$28.4M Buy
+220,693
New +$29.7M 0.24% 145

Other funds holding THG

Boston Trust Walden's THG Position: Q2 2026 in Review

Boston Trust Walden reduced its Hanover Insurance (THG) stake by 2% in Q2 2026, selling an estimated $522K and leaving 138,180 shares worth $29.6M. The position accounts for 0.23% of the portfolio, ranked #152.

Boston Trust Walden first reported a position in THG in Q1 2023 and has held it in 14 quarters since. The position peaked at $60.1M in Q1 2025. 546 funds tracked by Wall St. Rank hold THG as of Q2 2026.

  • Boston Trust Walden held 138,180 shares of Hanover Insurance worth $29.6M as of Q2 2026.
  • Boston Trust Walden sold 2,758 Hanover Insurance shares in Q2 2026, an estimated $522K.
  • Hanover Insurance made up 0.23% of Boston Trust Walden's portfolio in Q2 2026, its #152 holding.
  • Boston Trust Walden first reported a position in Hanover Insurance in Q1 2023 and has held it in 14 quarters since.
  • Boston Trust Walden's Hanover Insurance position peaked at $60.1M in Q1 2025.
  • 546 funds tracked by Wall St. Rank held Hanover Insurance as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.